Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2019-12-12 Delisting Announcement
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Assemblée Générale Mixte et Conseil d’Administration du 12 décembre 2019
Delisting Announcement Classification · 99% confidence The document is titled "Assemblée Générale Mixte et Conseil d'Administration du 12 décembre 2019" (Combined General Meeting and Board of Directors of December 12, 2019). It explicitly states that the General Meeting was held and adopted all proposed resolutions, including the transfer of listing and ratification of director co-optations. This content directly relates to the proceedings and outcomes of a shareholder meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (3771 chars) is substantial enough to be the primary material, not just an announcement of the meeting.
2019-12-12 French
Pixium Vision finaliste du 18ème Grand Prix de l’Innovation de la Ville de Paris
Regulatory Filings Classification · 95% confidence The document is a press release dated December 12, 2019, announcing that Pixium Vision has been selected as a finalist for the 18th Grand Prix de l'Innovation de la Ville de Paris. It details the company's technology (PRIMA system) and its application for patients with dry Age-related Macular Degeneration (AMD). This type of announcement, which communicates a specific, non-periodic corporate event (an award nomination) and provides general company/product information, does not fit the definitions for standard financial reports (10-K, IR, ER, MRQ) or specific corporate actions (DIV, CAP, DIRS). It is a general corporate update/news release. Since there is no specific category for 'Award Nomination Press Release' and it is not a standard regulatory filing like a 10-K or a report announcement (RPA), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory or significant corporate announcements that don't fit elsewhere.
2019-12-12 French
Pixium Vision reaches finalist status in 18th Paris Innovation Grand Prix award
Regulatory Filings Classification · 95% confidence The document is a press release dated December 12, 2019, announcing that Pixium Vision reached finalist status in the 18th Paris Innovation Grand Prix award for its Prima system. It details the company's technology, market focus (dry AMD), and future milestones (CE mark in 2023, FDA approval). This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a general corporate update about an award, partnership, or significant non-financial event, best fits the 'Regulatory Filings' (RNS) category as a general regulatory/corporate announcement, or potentially 'LTR' if the award was regulatory in nature, but RNS is the best general fit for press releases that don't match other specific categories like DIV, MANG, or TAR. Given the content is a general news announcement about an award, RNS (Regulatory Filings/General Announcement) is the most appropriate classification.
2019-12-12 English
Pixium Vision’s 2020 financial calendar
Report Publication Announcement Classification · 98% confidence The document explicitly announces the company's '2020 financial calendar' listing future dates for key events such as 'Full year 2019 financial results', 'Half year 2020 financial results', and the 'Annual General Shareholders' Meeting'. This is an announcement about the timing of future corporate reports and meetings, not the reports themselves. Since it is an announcement regarding the publication schedule of various reports (results, AGM), it fits best under Report Publication Announcement (RPA). It is not a specific report like 10-K, ER, or IR, nor is it a general regulatory filing (RNS) since RPA is more specific for scheduling announcements.
2019-12-11 English
Calendrier financier 2020 de Pixium Vision
Report Publication Announcement Classification · 98% confidence The document is a short announcement dated December 11, 2019, titled "Calendrier financier 2020" (Financial Calendar 2020). It lists future dates for key corporate events such as annual results, cash position updates, and the Annual General Meeting (AGM). Since the document's primary purpose is to announce the schedule for future report publications and meetings, and given its very short length (2680 characters), it fits the definition of a Report Publication Announcement (RPA) rather than being the actual report itself (like 10-K or ER).
2019-12-11 French
Information relative au nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2019" (Information relative to the total number of voting rights and shares comprising the share capital as of November 30, 2019). It explicitly details the total number of voting rights (real and theoretical) and the total number of shares, mentioning recent capital structure changes (issuance of new shares via ORNAN conversion). This content directly relates to the company's capital structure and share count, which aligns best with the 'Share Issue/Capital Change' category (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a dividend notice (DIV).
2019-12-02 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.